1. Introduction
===============

Despite long-standing interest in global biodiversity ([@bib9]), only recently has the diversity of human pathogens been catalogued ([@bib12]). Approximately 1400 pathogen species are currently recognized ([@bib14]). Fewer than 200 of these are viruses, but novel virus species are being reported in humans at a rate of over two per year, much faster than for other kinds of pathogen ([@bib14]). Novel viruses are a major public health concern, whether causing disease on the massive scale of HIV/AIDS, more transient events such as the SARS epidemic or potential future threats such as pandemic influenza. An analysis of temporal patterns of virus discovery is therefore of considerable interest.

Our analysis is based on the rate of accumulation of new human virus species: the 'discovery curve'. Discovery curves have previously been used to estimate the total diversity of various plant and animal taxa ([@bib5]; [@bib2]). However, to our knowledge, the discovery curves have not previously been compiled for any category of human pathogen. Having compiled the discovery curve, we proceed to develop a simple statistical model which we use to estimate the size of the pool of human virus species, *N*, and the expected rate of discovery of new species to 2020.

2. Material and methods {#sec2}
=======================

A standard method for estimating numbers of species is to extrapolate the cumulative species discovery curve ([@bib2]). We gathered data for this curve by systematically searching the primary literature for first reports of human infection with each of the currently recognized virus species, using species as defined by the International Committee on Taxonomy of Viruses (ICTV; <http://www.ictvonline.org/>). We note that the set of viruses we are interested in---those that can infect humans---is a small subset of the total (over 1500 species according to ICTV) and, as is discussed below, not a closed set because many of these viruses can also infect other hosts ([@bib12]). We regard this as analogous to constructing species discovery curves for any subdivision of geographical range or habitat. As we demonstrate below, this approach yields an excellent description of the discovery curve.

We used piecewise linear regression to test for changes in the slope of the discovery curve. The results suggested upswings in 1930 (95% CI, 1929--1933) and 1954 (1953--1956). We therefore restricted detailed analysis to the period 1954--2006.

We modelled discovery since 1954 assuming a total number of species available to be discovered (the species pool) of *N* virus species, each discovered in any given year with probability *p*. The model was fitted to the data and assessed using Markov chain Monte Carlo (MCMC)-based Bayesian inference, generating distributions and credible intervals for the parameters. The model defines the expected number of discovered viruses in year *t* as$$\lambda_{t}(N,p) = Np{(1 - p)}^{t - 1},$$where year *t*=1 corresponds to 1954.

The binomial distribution *B*(*N*, *p*) can be accurately approximated by a Poisson distribution with parameter *Np* for the range of values of *N* and *p* of interest. We considered fitting a distribution for values of *p*; however, provided individual *p*-values are low there is minimal improvement in model fit. Thus, for a set of model parameters, the likelihood of observing data, *X*={*x*~*i*~}, the number of viruses discovered for years 1 to *k*, is given by$$\left. L(X \middle| N,p) = \prod\limits_{i = 1}^{k}\frac{\text{exp}( - \lambda_{i}(N,p))\lambda_{i}^{x_{i}}(N,p)}{x_{i}!}. \right.$$Parameter distributions for *N* and *p* were calculated using MCMC simulation using a standard Metropolis algorithm with flat prior information. It was necessary to compute a correlation matrix to define a joint proposal since *N* and *p* are closely correlated. We monitored convergence using two chains. Once they had converged, we had a burn in period of 10^5^ samples.

We compared the model with the observed data by calculating the mean, trend in the mean and variance for the number of virus species discovered per year (based on five million simulations using best-fit parameter values). The model was extrapolated to year 2020 by calculating the expected number of viruses discovered using the best-fit model. The 95% posterior prediction intervals were calculated using two million model simulations taking into account parameter uncertainty (as given by data from 1954 to 2006) and natural model simulation stochasticity.

As a validation exercise, the model was also fitted to the curve for accumulated virus families from 1954 using the same methods, except that the Poisson approximation no longer holds, so a binomial distribution was used. A family (based on current ICTV classifications) was added to the total when the first post-1954 species was allocated to that family. We tested the assumption that species can be randomly assigned to families (weighted by the size of the families) by noting the number of years in which 0, 1, 2, etc. virus families were discovered. This was done one million times to obtain a distribution for comparison with the observed values.

3. Results
==========

From a comprehensive search of the primary literature, we found 188 virus species that have been reported to infect humans, going back to yellow fever virus in 1901 ([table 1](#tbl1){ref-type="table"}). Since then, the number of human virus species discovered in any given year has ranged from zero to six. As is typical ([@bib2]), the cumulative species discovery curve increases slowly initially and then more rapidly ([figure 1](#fig1){ref-type="fig"}). Piecewise linear regression suggests no further upswings since 1954, roughly corresponding to the advent of tissue culture techniques for virus detection ([figure 1](#fig1){ref-type="fig"}).

We confirmed that our model reproduced the observed slight downward trend in the rate of discovery since 1954 ([figure 1](#fig1){ref-type="fig"}) and the observed variance in the data from 1954 to 2006 ([figure 2](#fig2){ref-type="fig"}). The distribution of the number of virus species discovered per year shows slight overdispersion (mean=2.69; variance=3.07; variance-to-mean ratio greater than 1) which falls within the predicted range (mean=2.70 with 95% credible interval 2.41--3.00; variance=3.03 with interval 1.99--4.49). Together, these results support our choice of model, even though we do not explicitly consider heterogeneity in the probability of discovering a given species in any one year (*p*) or temporal variation in sampling effort, detection techniques and reporting.

Noting that *p* and *N* are highly correlated ([figure 3](#fig3){ref-type="fig"}), our best estimate for *p* is 0.015 (95% credible interval, 0.004--0.026) with 117 (38--562) so far undiscovered virus species. Extrapolating the discovery curve, allowing for parameter uncertainty and stochastic discovery, we obtain a best estimate of 22 new species (10--40) by 2020 ([figure 1](#fig1){ref-type="fig"}).

Data on the cumulative discovery of new virus families are also reproducible ([figure 4](#fig4){ref-type="fig"}). The predicted distribution of the number of virus families discovered per year (assuming random allocation of species to families) compares favourably with the observed distribution ([figure 5](#fig5){ref-type="fig"}). This provides further support for the appropriateness of our model.

4. Discussion
=============

We conclude that it is extremely probable that new human viruses will continue to be discovered in the immediate future; we are not yet close to the end of the virus discovery curve. As a direct result of this, it is not possible to estimate the size of the species pool for human viruses with precision. However, in contrast to the negative assessment by [@bib2] of the use of incomplete species accumulation curves, we consider that the upper and lower limits to our estimate of the size of the species pool are of interest and also have practical implications.

Current trends are consistent with a pool of at least 38 undiscovered species that will be reported at an average rate of at least approximately one per year to 2020. In this context, it is worth noting that three new species were reported in 2007: two polyoma viruses, Ki and Wu, and a reovirus, Melaka ([@bib1]; [@bib3]; [@bib6]). Other viruses may have been reported but not yet classified. In practice, future rates of discovery will, of course, be affected by any major advances in virus detection technology or by any major shifts (upwards or downwards) in the effort expended on virus discovery programmes. Tissue culture was regarded as the 'gold standard' for virus detection up until a few years ago when molecular methods came to the fore ([@bib11]), although there has not been a detectable increase in discovery rates as a result. Indeed, it is striking that there have been no dramatic changes in the pattern of virus discovery for over 50 years; extrapolations from our data should therefore provide a useful benchmark for probable future discovery rates.

The upper limit for *N* is finite but large; we cannot rule out hundreds of novel human viruses to be reported in the future. There are two (not mutually exclusive) possible explanations for such a high level of diversity. First, it could reflect the largely unknown extant diversity of viruses in the non-human animal reservoirs that constitute the major source of emerging human pathogens ([@bib12]; [@bib14]). The majority of human viruses are known to be capable of infecting non-human hosts (almost exclusively mammals and birds), and the animal origin of many apparently novel human viruses (e.g. HIV1 and HIV2, SARS CoV, Nipah virus) has been frequently remarked upon ([@bib10]; [@bib15]; [@bib13]); indeed, recently discovered viruses are even more likely to be associated with a non-human reservoir ([@bib14]). All these observations are consistent with the idea that a significant fraction of viruses discovered in the last few decades is ecological 'spillover' from animal populations rather than newly evolved specialist human viruses. We have very limited knowledge of the diversity of viruses present in most mammal and bird species (with most attention having been paid to viruses of domestic animals; [@bib4]), so it is unclear for how long this process might continue.

An alternative explanation for a large pool of human viruses is that this reflects a high rate of evolution (within a reservoir population) of truly novel species capable of infecting humans. This hypothesis is difficult to test directly without much more comprehensive sequence data from both human and non-human virus populations. We note that the finite upper limit for the current estimate of *N* does not necessarily imply that the process of virus discovery is not open-ended (as a result of the evolution of new species) since there could be a low background rate of virus evolution, which will remain once extant diversity has been fully revealed. The balance between revealing extant diversity and the continual evolution of new species could be explored using a more complex model than equation [(2.1)](#fd2.1){ref-type="disp-formula"}; however, the available data are insufficient to yield useful estimates of the additional parameters required.

Although we cannot know in advance how big a threat they will pose, novel human viruses must be anticipated in public health planning and surveillance programmes for emerging infectious diseases ([@bib8]; [@bib7]). However, current approaches to virus discovery are largely passive, usually relying on investigation of reports of human disease with unfamiliar clinical symptoms and uncertain aetiology. Recently, there have been calls for more active discovery programmes for viruses and other pathogens involving 'systematic sampling and phylogeographic analysis of related pathogens in diverse animal species' ([@bib13]). We consider that such calls are supported by the results reported here.
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![The discovery curve for human virus species. Cumulative number of species reported to infect humans (black circles and line). Statistically significant upward breakpoints are shown (vertical lines). Best-fit curve (solid line) and lower and upper 95% posterior prediction intervals (dashed lines) for extrapolation to 2020.](rspb20080294f01){#fig1}

![Approximate probability density of variance in simulated data from 1954 to 2006 for the best-fit model. Arrow shows observed value.](rspb20080294f02){#fig2}

![Approximate probability density function of parameter *p* and *N* generated by MCMC methods (see main text for details).](rspb20080294f03){#fig3}

![Accumulation of virus families associated with species discovered after 1954 (black circles and line). Best-fit curve (solid line) and lower and upper 95% posterior prediction intervals (dashed lines) extrapolated to 2020. Fitted parameter values are *N*=25 (95% credible intervals 24--37) and *p*=0.056 (0.027--0.089).](rspb20080294f04){#fig4}

![Frequency distribution for the number per year of virus families associated with species discovered from 1954 to 2006, generated by reassigning the discovered viruses to families, repeated 10^6^ times. Expected number with 95% credible intervals (bars) and data (black circles).](rspb20080294f05){#fig5}

###### 

List of viruses ordered by year of first report[a](#tblfn1){ref-type="table-fn"} of human infection.

  year   species                                  family
  ------ ---------------------------------------- ------------
  1901   Yellow fever virus                       flavi
  1903   Rabies virus                             rhabdo
  1907   Dengue virus                             flavi
  1907   Human papillomavirus                     papilloma
  1907   Molluscum contagiosum virus              pox
  1907   Variola virus                            pox
  1909   Poliovirus                               picorna
  1911   Measles virus                            paramyxo
  1919   Human herpesvirus 3                      herpes
  1921   Human herpesvirus 1                      herpes
  1931   Rift Valley fever virus                  bunya
  1933   Influenza A virus                        orthomyxo
  1933   Lymphocytic choriomeningitis virus       arena
  1933   St Louis encephalitis virus              flavi
  1934   Cercopithecine herpes virus 1            herpes
  1934   Japanese encephalitis virus              flavi
  1934   Louping ill virus                        flavi
  1934   Mumps virus                              paramyxo
  1934   Orf virus                                pox
  1937   Tick-borne encephalitis virus            flavi
  1938   Cowpox virus                             pox
  1938   Eastern equine encephalitis virus        toga
  1938   Rubella virus                            toga
  1938   Venezuelan equine encephalitis virus     toga
  1938   Western equine encephalitis virus        toga
  1940   Influenza B virus                        orthomyxo
  1940   West Nile virus                          flavi
  1941   Bwamba virus                             bunya
  1943   Newcastle disease virus                  paramyxo
  1944   Sandfly fever Naples virus               bunya
  1944   Sandfly fever Sicilian virus             bunya
  1946   Colorado tick fever virus                reo
  1947   Omsk haemorrhagic fever virus            flavi
  1948   Encephalomyocarditis virus               picorna
  1948   Human enterovirus C                      picorna
  1949   Human enterovirus A                      picorna
  1949   Human enterovirus B                      picorna
  1950   Influenza C virus                        orthomyxo
  1950   Vesicular stomatitis virus               rhabdo
  1951   Bunyamwera virus                         bunya
  1952   California encephalitis virus            bunya
  1952   Murray Valley encephalitis virus         flavi
  1952   Ntaya virus                              flavi
  1953   Human rhinovirus A                       picorna
  1954   Human adenovirus B                       adeno
  1954   Human adenovirus C                       adeno
  1954   Human adenovirus E                       adeno
  1955   Human adenovirus D                       adeno
  1956   Chikungunya virus                        toga
  1956   Human herpesvirus 5                      herpes
  1956   Human parainfluenza virus 2              paramyxo
  1956   Ilheus virus                             flavi
  1957   Human adenovirus A                       adeno
  1957   Human respiratory syncytial virus        paramyxo
  1957   Kyasanur forest disease virus            flavi
  1957   Mayaro virus                             toga
  1957   Wesselsbron virus                        flavi
  1958   Human parainfluenza virus 1              paramyxo
  1958   Human parainfluenza virus 3              paramyxo
  1958   Human parechovirus                       picorna
  1958   Junin virus                              arena
  1959   Banzi virus                              flavi
  1959   Guaroa virus                             bunya
  1959   Powassan virus                           flavi
  1960   Human parainfluenza virus 4              paramyxo
  1960   Human rhinovirus B                       picorna
  1961   Caraparu virus                           bunya
  1961   Catu virus                               bunya
  1961   O\'nyong-nyong virus                     toga
  1961   Oropouche virus                          bunya
  1962   Rio Bravo virus                          flavi
  1962   Sindbis virus                            toga
  1963   Equine rhinitis virus A                  picorna
  1963   Great Island virus                       reo
  1963   Pseudocowpox virus                       pox
  1963   Yaba monkey tumour virus                 pox
  1964   Human herpesvirus 4                      herpes
  1964   Machupo virus                            arena
  1964   Zika virus                               flavi
  1965   Chagres virus                            bunya
  1965   Foot and mouth disease virus             picorna
  1965   Tanapox virus                            pox
  1965   Wyeomyia virus                           bunya
  1966   Changuinola virus                        reo
  1966   Human coronavirus 229E                   corona
  1966   Quaranfil virus                          unassigned
  1966   Saimiriine herpesvirus 1                 herpes
  1967   Chandipura virus                         rhabdo
  1967   Crimean-Congo haemorrhagic fever virus   bunya
  1967   Human coronavirus OC43                   corona
  1967   Human enterovirus D                      picorna
  1967   Piry virus                               rhabdo
  1967   Tacaiuma virus                           bunya
  1968   Human herpesvirus 2                      herpes
  1968   Marburg virus                            filo
  1968   Tataguine virus                          bunya
  1970   Everglades virus                         toga
  1970   Hepatitis B virus                        hepadna
  1970   Lassa virus                              arena
  1970   Punta Toro virus                         bunya
  1971   Aroa virus                               flavi
  1971   BK virus                                 polyoma
  1971   Duvenhage virus                          rhabdo
  1971   JC virus                                 polyoma
  1971   Vaccinia virus                           pox
  1972   Bovine papular stomatitis virus          pox
  1972   Mokola virus                             rhabdo
  1972   Monkeypox virus                          pox
  1972   Norwalk virus                            calici
  1972   Ross River virus                         toga
  1973   Bangui virus                             bunya
  1973   Dugbe virus                              bunya
  1973   Hepatitis A virus                        picorna
  1973   Kotonkan virus                           rhabdo
  1973   Rotavirus A                              reo
  1973   Tamdy virus                              bunya
  1974   Getah virus                              toga
  1975   B19 virus                                parvo
  1975   Bhanja virus                             bunya
  1975   Human astrovirus                         astro
  1975   Lebombo virus                            reo
  1975   Shuni virus                              bunya
  1975   Thogoto virus                            orthomyxo
  1976   Orungo virus                             reo
  1976   Wanowrie virus                           bunya
  1977   Hepatitis delta virus                    unassigned
  1977   Sudan Ebola virus                        filo
  1977   Zaire Ebola virus                        filo
  1978   Hantaan virus                            bunya
  1978   Issyk-Kul virus                          bunya
  1980   Human T-lymphotropic virus 1             retro
  1980   Puumala virus                            bunya
  1982   Human T-lymphotropic virus 2             retro
  1982   Seoul virus                              bunya
  1983   Candiru virus                            bunya
  1983   Hepatitis E virus                        unassigned
  1983   Human adenovirus F                       adeno
  1983   Human immunodeficiency virus 1           retro
  1984   Human torovirus                          corona
  1984   Rotavirus B                              reo
  1985   Borna disease virus                      borna
  1986   European bat lyssavirus 2                rhabdo
  1986   Human herpesvirus 6                      herpes
  1986   Human immunodeficiency virus 2           retro
  1986   Kasokero virus                           bunya
  1986   Kokobera virus                           flavi
  1986   Rotavirus C                              reo
  1987   Dhori virus                              orthomyxo
  1987   Sealpox virus                            pox
  1987   Suid herpesvirus 1                       herpes
  1988   Barmah Forest virus                      toga
  1988   Picobirnavirus                           birna
  1989   European bat lyssavirus 1                rhabdo
  1989   Hepatitis C virus                        flavi
  1990   Banna virus                              reo
  1990   Gan Gan virus                            bunya
  1990   Reston Ebola virus                       filo
  1990   Semliki Forest virus                     toga
  1990   Trubanaman virus                         bunya
  1991   Guanarito virus                          arena
  1992   Dobrava-Belgrade virus                   bunya
  1993   Sin Nombre virus                         bunya
  1994   Hendra virus                             paramyxo
  1994   Human herpesvirus 7                      herpes
  1994   Human herpesvirus 8                      herpes
  1994   Sabia virus                              arena
  1995   Bayou virus                              bunya
  1995   Black Creek Canal virus                  bunya
  1995   Cote d\'Ivoire Ebola virus               filo
  1995   Hepatitis G virus                        flavi
  1995   New York virus                           bunya
  1996   Andes virus                              bunya
  1996   Australian bat lyssavirus                rhabdo
  1996   Juquitiba virus                          bunya
  1996   Usutu virus                              flavi
  1997   Laguna Negra virus                       bunya
  1998   Menangle virus                           paramyxo
  1999   Nipah virus                              paramyxo
  1999   Torque teno virus                        circo
  2000   Whitewater Arroyo virus                  arena
  2001   Baboon cytomegalovirus                   herpes
  2001   Human metapneumovirus                    paramyxo
  2003   SARS coronavirus                         corona
  2004   Human coronavirus NL63                   corona
  2005   Human bocavirus                          parvo
  2005   Human coronavirus HKU1                   corona
  2005   Human T-lymphotropic virus 3             retro
  2005   Human T-lymphotropic virus 4             retro
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